Skip to main content
OpenTrials

Clinical trial condition

Narcolepsy

Explore clinical trials studying Narcolepsy. Study availability and eligibility vary by location and protocol.

88 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Narcolepsy trial results

Completed

Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)

NCT03881852

Conditions
Cataplexy, Cataplexy Narcolepsy, Disorders of Excessive Somnolence, +7 more
Locations
  • CONCERT Study Site Birmingham, Alabama, United States
  • CONCERT Study Site Alameda, California, United States
  • CONCERT Study Site Santa Ana, California, United States
  • CONCERT Study Site Boulder, Colorado, United States
View all 14 locations
View Trial Details
Completed

A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy

NCT05059223

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +6 more
Locations
  • Clinical Research Site Alabaster, Alabama, United States
  • Clinical Research Site Peoria, Arizona, United States
  • Clinical Research Site Phoenix, Arizona, United States
  • Clinical Research Site Redwood City, California, United States
View all 50 locations
View Trial Details
Completed

A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy

NCT05869773

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +4 more
Locations
  • Science 37 Culver City, California, United States
  • M3 Wake Research Encino, California, United States
  • So Cal Clinical Research Huntington Beach, California, United States
  • Long Beach Research Institute Lakewood, California, United States
View all 43 locations
View Trial Details
Completed

Observational Study of LUMRYZ in Narcolepsy

NCT06792708

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +4 more
Locations
  • Jeremy D McConnell, MD PA Bradenton, Florida, United States
  • Comprehensive Sleep Center East Lansing, Michigan, United States
  • Patient First MD Middletown, New Jersey, United States
  • Ghaly Sleep Management Services East Syracuse, New York, United States
View Trial Details
Completed

A Study of HBS-201 (Pitolisant Delayed-release)

NCT07051252

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +4 more
Locations
  • Harmony Site 9 San Ramon, California, United States
  • Harmony Site 14 Brandon, Florida, United States
  • Harmony Site 4 Miami, Florida, United States
  • Harmony Site 8 Atlanta, Georgia, United States
View all 15 locations
View Trial Details
Completed

A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)

NCT05113745

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +6 more
Locations
  • Clinical Research Site Phoenix, Arizona, United States
  • Clinical Research Site Boulder, Colorado, United States
  • Clinical Research Site Colorado Springs, Colorado, United States
  • Clinical Research Site Brandon, Florida, United States
View all 25 locations
View Trial Details
Completed

An Open Label Study of FT218 in Subjects With Narcolepsy

NCT04451668

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +12 more
Locations
  • Sleep Disorders Center of Alabama Birmingham, Alabama, United States
  • Stanford Sleep Medicine Redwood City, California, United States
  • SDS Clinical Trials Santa Ana, California, United States
  • Alpine Clinical Research Center Boulder, Colorado, United States
View all 29 locations
View Trial Details

Related conditions